July 2010- 2011 Exhibition Programme
Britannia Pharmaceuticals Ltd have committed to exhibiting at two shows in the first quarter of 2011. We will be attending the 1st Meeting of WFN & ANEI Parkinson's Disease & Movement Disorders, taking place 8th-9th January 2011 at the Sheraton Hotel in Kolkata and the AOPMC 2011 show taking place March 25th-27th in Taipei. The website for the AOPMC Congress is:http://www.aopmc2011taiwan.com/

April 2010 - Meet Us in China!
We will be attending ChinaBio® Partnering Forum in Suzhou, China on June 23-24 2010. Send us a meeting request through the partnering system or email us in advance here

The meeting event information is available here

December 2009 - APO-hub launched. The hub for our apomorphine product has gone live at www.apo-hub.com, detailing what apomorphine is and basic information on Parkinson's Disease.

November 2009 - Britannia Pharmaceuticals has previously taken apomorphine nasal powder through to phase III clinical trials in patients with Parkinson’s disease. In these trials apomorphine nasal powder demonstrated clinical efficacy in relieving the ‘off’ periods of the mid to late stages of disease. Unfortunately the trials were stopped due to patient withdrawals as a result of reversible local irritation in the lower nostril.

Currently Britannia Pharmaceuticals has stopped development of apomorphine nasal powder but is interested to hear from parties that have a nasal delivery device that could prevent the accumulation of powder in the lower nose.